Preparation method of (4S, 5R)-3-(N-fluorenylmethoxycarbonyl alanyl)-2, 2, 5-trimethyl oxazolidine-4-carboxylic acid dipeptide
By using ethyl acetate as a solvent and atmospheric distillation reaction in solid-phase polypeptide synthesis, the pseudoproline cyclization reaction was optimized, and the problems of poor solubility and high boiling point solvents were solved, achieving high efficiency and environmental protection (4S,5R) Preparation of -3-(N-fluorenemethoxycarbonylalanyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid dipeptide improves product purity and yield.
Patent Information
- Application Number
- CN202411207622.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-30
- Publication Date
- 2024-12-06
AI Technical Summary
In the synthesis of solid-phase polypeptides, poor solubility of the peptide leads to aggregation of the peptide chain and incomplete amino acid coupling. The existing methods use high-boiling solvents such as toluene and tetrahydrofuran, which leads to a decrease in the purity of the reaction product and violates environmental protection regulations.
Ethyl acetate is used as the reaction solvent, and the atmospheric distillation reaction catalyzed by pyridine 4-methylbenzenesulfonate salt is adjusted to adjust the feeding speed and temperature, and the treatment steps of triethylamine, ethyl acetate and water are combined to optimize the pseudoproline. Acid cyclosynthesis reaction.
It improves the yield and purity of the product, reduces side reactions, is convenient to operate, efficient reaction, environmentally friendly reagents, and is suitable for industrial implementation.
Smart Images

Figure BDA0005019465650000011 
Figure BDA0005019465650000021 
Figure BDA0005019465650000031
Abstract
Description
Technical Field
[0001] The present invention relates to a method for preparing a (4S,5R)-3-(N-fluorenylmethoxycarbonylalanyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid dipeptide, and in particular to a method for preparing a (4S,5R)-3-(N-fluorenylmethoxycarbonylalanyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid dipeptide that is efficient and environmentally friendly. Background Art
[0002] In solid-phase peptide synthesis (SPPS), poor peptide solubility is a major challenge in synthesis and purification. If peptides form secondary structures such as α-helices or β-sheets during synthesis, their solubility will be further impaired, leading to peptide chain aggregation, incomplete amino acid coupling, and the formation of missing peptides. Introducing pseudoproline during synthesis can effectively inhibit β-sheet formation, thereby increasing the solubility of the peptide chain in solution. (4S,5R)-3-(N-Fluorenylmethoxycarbonylalanyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid dipeptide is a type of pseudoproline dipeptide and is an important intermediate in the preparation of semaglutide.
[0003]
[0004] (4S,5R)-3-(N-Fluorenylmethoxycarbonylalanyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid dipeptide
[0005] In existing methods for preparing glycine dipeptides, the solvents used in the cyclization reaction to construct the oxazolidine are toluene or toluene / tetrahydrofuran. Due to the high boiling points of these solvents, distillation is demanding. Furthermore, as the reaction proceeds, side reactions increase, resulting in a decrease in the purity of the reaction product. Furthermore, toluene and tetrahydrofuran are Class II solvents as defined by the International Conference on Chemical Conduct (ICH), restricting their use and requiring strict limits for residual solvents in pharmaceuticals. Summary of the Invention
[0006] Purpose of the invention: The present invention aims to provide a convenient, efficient and environmentally friendly industrial method for preparing (4S,5R)-3-(N-fluorenylmethoxycarbonylalanyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid dipeptide.
[0007] Technical solution: The preparation method of the (4S,5R)-3-(N-fluorenylmethoxycarbonylalanyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid dipeptide of the present invention is to react compound 2 with dimethoxypropane in ethyl acetate via catalytic distillation with 4-methylbenzenesulfonic acid pyridinium salt to obtain the dipeptide compound 3:
[0008]
[0009] Preferably, the molar ratio of compound 2, 4-methylbenzenesulfonic acid pyridinium salt and dimethoxypropane is 1:(0.15-0.25):(9-11).
[0010] More preferably, the molar ratio of compound 2, 4-methylbenzenesulfonic acid pyridinium salt and dimethoxypropane is 1:0.2:10.
[0011] More preferably, half the mass of dimethoxypropane is first added to the reaction system, and the remainder is added during the distillation reaction after the temperature is raised.
[0012] Preferably, the distillation reaction is a normal pressure distillation reaction; during the distillation reaction, the feeding rate of dimethoxypropane is consistent with the distillate rate.
[0013] More preferably, during the distillation reaction, the feeding rate of dimethoxypropane is 9 to 11 L / h.
[0014] More preferably, during the distillation reaction, the feeding rate of dimethoxypropane is 10 L / h.
[0015] Preferably, the reaction temperature of the distillation reaction is 68-78°C.
[0016] Preferably, when conducting the distillation reaction, the dimethoxypropane is first dissolved in 30% to 40% of ethyl acetate based on the total mass of the reaction solvent, and then added to the reaction system.
[0017] More preferably, when performing the distillation reaction, the dimethoxypropane is first dissolved in 1 / 3 of ethyl acetate based on the total mass of the reaction solvent, and then added to the reaction system.
[0018] Preferably, after the distillation reaction is completed, the post-processing comprises the following steps:
[0019] (1) adding triethylamine to the reaction system and distilling under reduced pressure;
[0020] (2) adding ethyl acetate and water to the residue, retaining the organic phase, and extracting the aqueous phase with ethyl acetate;
[0021] (3) The organic phases are combined, washed, dried, concentrated, crystallized, and separated to obtain the dipeptide compound 3.
[0022] More preferably, the amount of triethylamine added in step (1) is 0.2 to 0.25 eq.
[0023] More preferably, the amount of triethylamine added in step (1) is 0.22 eq.
[0024] Further preferably, the mass ratio of ethyl acetate to water added in step (2) is (1.2-1.5):1.
[0025] More preferably, the mass ratio of ethyl acetate to water added in step (2) is 1.4:1.
[0026] The preparation method of compound 2 of the present invention comprises the following steps:
[0027] (1) Fmoc-L-alanine (Fmoc-L-Ala-OH) and N-hydroxysuccinimide (HOSu) are condensed with 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI·HCl) to form compound 1:
[0028]
[0029] (2) Compound 1 reacts with L-threonine under alkaline conditions, and then the reaction product is salified with N,N-dimethylethylenediamine, purified, and then liberated to obtain Compound 2:
[0030]
[0031] Preferably, the molar ratio of Fmoc-L-alanine, EDCI·HCl and HOSu in step (1) is 1:1.2-1.4:1.2-1.4, more preferably 1:1.3:1.3.
[0032] Preferably, the reaction solvent in step (1) is a mixed solvent of DMF:THF=1:4 (mass ratio); the reaction temperature is 20-25°C; and no post-treatment is required after the reaction, and the reaction solution is directly used in the next step.
[0033] Preferably, the base in step (2) is lithium hydroxide-lithium carbonate, and the molar ratio of lithium hydroxide, lithium carbonate and compound 1 is 2:0.8:1.
[0034] Preferably, the reaction temperature of step (2) is 10-20° C.; after the reaction is completed, the pH is adjusted to 2-3 for extraction treatment; more preferably, 20% H 2 SO 4 is used to adjust the pH to 2-3.
[0035] Preferably, in the salt formation process of step (2), ethanol is used as the solvent, and the molar ratio of N,N-dimethylethylenediamine to the crude compound 2 is 1:1.
[0036] Beneficial effects: Compared with the prior art, the present invention has the following significant advantages:
[0037] The present invention optimizes the pseudoproline cyclization reaction, adopts ethyl acetate with a lower boiling point and greater environmental friendliness as a reaction solvent, and adjusts the feeding speed so that the distillation reaction can be carried out under normal pressure. This accelerates the reaction process, reduces the occurrence of side reactions, and improves the product yield and purity. The invention has the advantages of convenient operation, high reaction efficiency, and environmentally friendly reagents, and is more conducive to industrial implementation. BRIEF DESCRIPTION OF THE DRAWINGS
[0038] Figure 1 The target product prepared in Example 1 1 H-NMR spectrum;
[0039] Figure 2 This is the HPLC purity test spectrum of the target product prepared in Example 1;
[0040] Figure 3 This is the HPLC detection pattern of the reaction control in Example 1;
[0041] Figure 4 This is the HPLC detection spectrum of the reaction in comparative example 1;
[0042] Figure 5 This is the HPLC detection spectrum of the reaction in comparative example 2. DETAILED DESCRIPTION
[0043] Example 1: Preparation of (4S,5R)-3-(N-fluorenylmethoxycarbonylalanyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid dipeptide (Compound 3) (Ethyl acetate as solvent)
[0044] (1) Preparation of N-Fmoc-L-alanine succinimide ester (Compound 1)
[0045]
[0046] 2.5 kg (1.0 eq) of Fmoc-L-alanine (Fmoc-L-Ala-OH) and 1.2 kg of N-hydroxysuccinimide (HOSu) were added to a reactor at 20 ° C. and dissolved in 15.0 kg of tetrahydrofuran (THF) for later use. In another reactor, 2.0 kg (1.3 eq) of EDCI, 5.0 kg of N, N-dimethylformamide (DMF) and 5.0 kg of THF were added sequentially, and then the reserved liquid was added dropwise to the reactor. HPLC detection of Fmoc-L-Ala-OH ≤ 2.0% was the reaction end point. No post-treatment was required to obtain the Fmoc-L-Ala-Osu reaction solution for later use. The HPLC purity was 94.54%, and the next step was carried out with a yield of 100%.
[0047] (2) Preparation of Fmoc-L-Ala-Thr-OH (Compound 2)
[0048]
[0049] To a 100L reactor, 2.87kg (3.0eq) of L-threonine, 0.47kg (0.8eq) of lithium carbonate, 0.39kg (2.0eq) of lithium hydroxide, and 17.0kg of water were added sequentially, stirred, and cooled to -5-0°C. The Fmoc-L-Ala-Osu standby reaction solution (approximately 30kg) was slowly added dropwise. After the addition was complete, the temperature was raised to 10-20°C. The reaction endpoint was determined by HPLC detection of Fmoc-L-Ala-Osu ≤ 0.1%. After the reaction was complete, the temperature was lowered to -5-0°C, 20% H2SO4 was added dropwise to adjust the pH to 2-3. After the addition was complete, the reaction was returned to room temperature, allowed to stand and separate, and the organic phase was temporarily stored. The aqueous phase was extracted with 10.0×2kg of ethyl acetate. The combined organic phases were washed with 3.0×3kg of saturated brine, dried with 3.28kg of anhydrous sodium sulfate, filtered, and the filter cake was washed with 3.28kg of ethyl acetate. The mixture was concentrated under reduced pressure at 35-45°C until no distillate remained. The obtained crude product was salified with N,N-dimethylethylenediamine in ethanol, filtered, dried under vacuum at 30-40°C, freed, and concentrated to obtain compound 2 as an off-white solid. The feed was carried out according to a 100% yield, and the HPLC purity was 99.26%.
[0050] (3) Preparation of (4S,5R)-3-(N-fluorenylmethoxycarbonylalanyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid dipeptide (Compound 3)
[0051]
[0052] To a 100L reactor, 4.5kg (1.0eq, theoretical amount) of Fmoc-L-Ala-Thr-OH compound 2, 45kg of ethyl acetate, 0.5kg (0.2eq) of 4-methylbenzenesulfonic acid pyridinium salt, and 5.7kg (5.0eq) of 2,2-dimethoxypropane were added in sequence. The mixture was heated to 68-78°C and distilled under normal pressure. A mixed solution of 5.7kg (5.0eq) of 2,2-dimethoxypropane and 22.0kg of ethyl acetate was added dropwise while distilling, and the addition rate was kept consistent with that of the distillate as much as possible. The product purity was 88.06% (HPLC) during the reaction for 1h. Figure 3, Table 2), HPLC detection Fmoc-L-Ala-Thr-OH ≤ 5.0% is the reaction end point, the temperature is lowered to 15-20 ° C, 0.24 kg (0.22 eq) of triethylamine is added, stirred for 30 min, and concentrated under reduced pressure at 30-40 ° C until there is no distillate, 18.0 kg of ethyl acetate and 13.0 kg of water are added and stirred to dissolve, the layers are separated, the aqueous phase is extracted with 9.0 × 2 kg of ethyl acetate, the organic phases are combined, washed with 9.0 × 2 kg of water and 9.0 kg of saturated sodium chloride in sequence, and dried over 5.0 kg of anhydrous sodium sulfate. The mixture was filtered, washed with an appropriate amount of ethyl acetate, and concentrated under reduced pressure at 30-40°C until no distillate was produced. The concentrate was crystallized and dried under vacuum at 30-35°C for ≥12 h to obtain 2.6 kg of (4S,5R)-3-(N-fluorenylmethoxycarbonylalanyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid as an off-white solid. The overall yield of the three-step reaction was 82.4%, and the HPLC purity was 99.95% (Table 1, Figure 2 ). 1 H NMR (400MHz, DMSO) δ13.13(d,J=251.6Hz,1H),7.90(d,J=7.5Hz,2H),7.75(dd,J=14.1,7.3Hz,2H),7.42(t,J=7.4Hz,2H),7.34(td,J=6. 4,2.7Hz,3H),4.47-4.06(m,6H),1.75(s,1H),1.57(d,J=13.7Hz,3H),1.49(s,2H),1.35(dd,J=22.4,5.9Hz,3H),1.24(d,J=6.9Hz,3H).
[0053] Table 1 HPLC purity test results of the target product of Example 1
[0054]
[0055] Table 2 HPLC test results of the reaction control in Example 1
[0056]
[0057] Comparative Example 1: Preparation of (4S,5R)-3-(N-fluorenylmethoxycarbonylalanyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid dipeptide (Compound 3) (Tetrahydrofuran as reaction solvent)
[0058] To a 100L reactor, 45g (1.0eq, theoretical amount) of Fmoc-L-Ala-Thr-OH compound 2, 450g of THF, 5g (0.2eq) of 4-methylbenzenesulfonic acid pyridinium salt, and 57g (5.0eq) of 2,2-dimethoxypropane were added in sequence. The temperature was raised to 68-78°C and distilled under normal pressure. A mixed solution of 57g (5.0eq) of 2,2-dimethoxypropane / 220g of tetrahydrofuran was added dropwise while distilling, and the addition rate was kept consistent with that of the distillate as much as possible. The product purity was 38.35% (HPLC) during the reaction for 6h. Figure 4 , Table 3), the reaction effect was general, and the reaction was terminated.
[0059] Table 3 HPLC test results of the reaction in comparative example 1
[0060]
[0061] Comparative Example 2: Preparation of (4S,5R)-3-(N-fluorenylmethoxycarbonylalanyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid dipeptide (Compound 3) (Toluene as reaction solvent)
[0062] To a 100L reactor, 45g (1.0eq, theoretical amount) of Fmoc-L-Ala-Thr-OH compound 2, 450g of toluene, 5g (0.2eq) of 4-methylbenzenesulfonic acid pyridinium salt, and 57g (5.0eq) of 2,2-dimethoxypropane were added in sequence. The temperature was raised to 68-78°C and distilled under normal pressure. A mixed solution of 57g (5.0eq) of 2,2-dimethoxypropane / 220g of toluene was added dropwise while distilling, and the addition rate was kept consistent with the distillate as much as possible. The product purity was 40.07% (HPLC) during the reaction for 6h. Figure 5 , Table 4), the reaction effect was general and the reaction was terminated.
[0063] Table 4 HPLC test results of the reaction in comparative example 2
[0064]
[0065] In summary, when toluene and tetrahydrofuran are used as reaction solvents, the reaction efficiency is poor due to the high boiling points of the two solvents; however, the present invention uses ethyl acetate as the reaction solvent, and the reaction efficiency is significantly improved.
Claims
1. A method for preparing a (4S,5R)-3-(N-fluorenylmethoxycarbonylalanyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid dipeptide, It is characterized in that The dipeptide compound 3 is obtained by reacting compound 2 with dimethoxypropane in ethyl acetate via catalytic distillation with 4-methylbenzenesulfonic acid pyridinium salt:
2. The preparation method according to claim 1, It is characterized in that The molar ratio of compound 2, 4-methylbenzenesulfonic acid pyridinium salt and dimethoxypropane is 1:(0.15-0.25):(9-11).
3. The preparation method according to claim 2, It is characterized in that The molar ratio of compound 2, 4-methylbenzenesulfonic acid pyridinium salt and dimethoxypropane is 1:0.2:
10.
4. The preparation method according to claim 1, It is characterized in that The distillation reaction is a normal pressure distillation reaction; when the distillation reaction is carried out, the feeding speed of dimethoxypropane is consistent with the distillate speed.
5. The preparation method according to claim 4, It is characterized in that During the distillation reaction, the feeding rate of dimethoxypropane is 9 to 11 L / h.
6. The preparation method according to claim 1, It is characterized in that The reaction temperature of the distillation reaction is 68-78°C.
7. The preparation method according to claim 1, It is characterized in that Based on the total mass of the reaction solvent, when conducting the distillation reaction, dimethoxypropane is first dissolved in 30% to 40% of ethyl acetate and then added into the reaction system.
8. The preparation method according to claim 1, It is characterized in that After the distillation reaction is completed, the post-treatment comprises the following steps: (1) adding triethylamine to the reaction system and distilling under reduced pressure; (2) adding ethyl acetate and water to the residue, retaining the organic phase, and extracting the aqueous phase with ethyl acetate; (3) The organic phases are combined, washed, dried, concentrated, crystallized, and separated to obtain the dipeptide compound 3.
9. The preparation method according to claim 8, It is characterized in that The amount of triethylamine added in step (1) is 0.2 to 0.25 eq.
10. The preparation method according to claim 8, It is characterized in that The mass ratio of ethyl acetate to water added in step (2) is (1.2-1.5):1.
